3/16
10:58 am
insm
Insmed (INSM) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Low
Report
Insmed (INSM) is now covered by Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
3/10
11:02 am
insm
Insmed Incorporated (INSM) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
Low
Report
Insmed Incorporated (INSM) Presents at Leerink Global Healthcare Conference 2026 Transcript [Seeking Alpha]
3/5
07:00 am
insm
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Medium
Report
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3/3
08:35 am
insm
Is It Time To Reassess Insmed (INSM) After A 92% One Year Surge? [Yahoo! Finance]
Low
Report
Is It Time To Reassess Insmed (INSM) After A 92% One Year Surge? [Yahoo! Finance]
3/2
12:23 pm
insm
Insmed Incorporated (INSM) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
Low
Report
Insmed Incorporated (INSM) Presents at TD Cowen 46th Annual Health Care Conference Transcript [Seeking Alpha]
3/1
01:39 am
insm
Insmed Incorporated (INSM) Enters 2026 With Momentum [Yahoo! Finance]
Medium
Report
Insmed Incorporated (INSM) Enters 2026 With Momentum [Yahoo! Finance]
2/27
12:00 am
insm
Why Insmed Incorporated (INSM) is One of the Best Strong Buy Healthcare Stocks to Invest In [Yahoo! Finance]
Low
Report
Why Insmed Incorporated (INSM) is One of the Best Strong Buy Healthcare Stocks to Invest In [Yahoo! Finance]
2/25
08:23 am
insm
Melodia Therapeutics Announces U.S. Patent Grant Covering MLD-151 [Yahoo! Finance]
Medium
Report
Melodia Therapeutics Announces U.S. Patent Grant Covering MLD-151 [Yahoo! Finance]
2/24
08:54 am
insm
Insmed (NASDAQ:INSM) had its price target lowered by analysts at Mizuho from $211.00 to $204.00. They now have an "outperform" rating on the stock.
Low
Report
Insmed (NASDAQ:INSM) had its price target lowered by analysts at Mizuho from $211.00 to $204.00. They now have an "outperform" rating on the stock.
2/24
07:30 am
insm
Insmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE [Yahoo! Finance]
Low
Report
Insmed Incorporated (INSM) Gained from Its Lead Product ARIKAYCE [Yahoo! Finance]
2/23
08:04 am
insm
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $230.00 price target on the stock.
Low
Report
Insmed (NASDAQ:INSM) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $230.00 price target on the stock.
2/20
11:04 am
insm
Insmed Q4 Reinforces Confidence in Brinsupri Growth, RBC Says [Yahoo! Finance]
Low
Report
Insmed Q4 Reinforces Confidence in Brinsupri Growth, RBC Says [Yahoo! Finance]
2/20
10:57 am
insm
Insmed (NASDAQ:INSM) was given a new $166.00 price target on by analysts at Morgan Stanley.
Low
Report
Insmed (NASDAQ:INSM) was given a new $166.00 price target on by analysts at Morgan Stanley.
2/20
07:18 am
insm
Insmed (NASDAQ:INSM) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
Low
Report
Insmed (NASDAQ:INSM) had its "overweight" rating reaffirmed by analysts at Wells Fargo & Company.
2/20
04:07 am
insm
Insmed (INSM) Poised for 2026 Upside With Potential $1.3B Arikayce Sales Boost, Roth/MKM Initiates Buy [Yahoo! Finance]
Low
Report
Insmed (INSM) Poised for 2026 Upside With Potential $1.3B Arikayce Sales Boost, Roth/MKM Initiates Buy [Yahoo! Finance]
2/19
03:08 pm
insm
Insmed (NASDAQ:INSM) was given a new $205.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Insmed (NASDAQ:INSM) was given a new $205.00 price target on by analysts at Stifel Nicolaus.
2/19
12:45 pm
insm
Insmed Incorporated Q4 2025 Earnings Call Summary [Yahoo! Finance]
Low
Report
Insmed Incorporated Q4 2025 Earnings Call Summary [Yahoo! Finance]
2/19
11:43 am
insm
Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
Low
Report
Insmed (INSM) Reports Q4 Earnings: What Key Metrics Have to Say [Yahoo! Finance]
2/19
09:49 am
insm
Insmed Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Insmed Q4 Earnings Call Highlights [Yahoo! Finance]
2/19
09:23 am
insm
Insmed (INSM) Reports Q4 Loss, Lags Revenue Estimates [Yahoo! Finance]
Medium
Report
Insmed (INSM) Reports Q4 Loss, Lags Revenue Estimates [Yahoo! Finance]
2/19
09:16 am
insm
Insmed (NASDAQ:INSM) was given a new $211.00 price target on by analysts at Mizuho.
Medium
Report
Insmed (NASDAQ:INSM) was given a new $211.00 price target on by analysts at Mizuho.
2/19
07:20 am
insm
Insmed: Q4 Earnings Snapshot [Yahoo! Finance]
High
Report
Insmed: Q4 Earnings Snapshot [Yahoo! Finance]
2/19
07:00 am
insm
Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update
Medium
Report
Insmed Reports Fourth-Quarter and Full-Year 2025 Financial Results and Provides Business Update
2/18
10:45 pm
insm
How Recent Analyst Shifts And Brinsupri Milestones Are Reframing The Insmed (INSM) Story [Yahoo! Finance]
Medium
Report
How Recent Analyst Shifts And Brinsupri Milestones Are Reframing The Insmed (INSM) Story [Yahoo! Finance]
2/15
08:14 pm
insm
Assessing Insmed (INSM) Valuation After Strong One Year Return And Recent Share Price Pullback [Yahoo! Finance]
Low
Report
Assessing Insmed (INSM) Valuation After Strong One Year Return And Recent Share Price Pullback [Yahoo! Finance]